189 related articles for article (PubMed ID: 21757444)
1. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging.
Hipp SJ; Steffen-Smith E; Hammoud D; Shih JH; Bent R; Warren KE
Neuro Oncol; 2011 Aug; 13(8):904-9. PubMed ID: 21757444
[TBL] [Abstract][Full Text] [Related]
2. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.
Steffen-Smith EA; Shih JH; Hipp SJ; Bent R; Warren KE
J Neurooncol; 2011 Nov; 105(2):365-73. PubMed ID: 21567301
[TBL] [Abstract][Full Text] [Related]
5. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
[TBL] [Abstract][Full Text] [Related]
6. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
7. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
Goda JS; Dutta D; Raut N; Juvekar SL; Purandare N; Rangarajan V; Arora B; Gupta T; Kurkure P; Jalali R
Pediatr Neurosurg; 2013; 49(5):274-81. PubMed ID: 25277867
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
10. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
[TBL] [Abstract][Full Text] [Related]
11. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
[TBL] [Abstract][Full Text] [Related]
13. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
14. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
[TBL] [Abstract][Full Text] [Related]
15. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
16. Correlation of multimodal
Morana G; Tortora D; Bottoni G; Puntoni M; Piatelli G; Garibotto F; Barra S; Giannelli F; Cistaro A; Severino M; Verrico A; Milanaccio C; Massimino M; Garrè ML; Rossi A; Piccardo A
Theranostics; 2020; 10(26):11881-11891. PubMed ID: 33204317
[TBL] [Abstract][Full Text] [Related]
17. Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy.
Signoretti S; Marmarou A; Aygok GA; Fatouros PP; Portella G; Bullock RM
J Neurosurg; 2008 Jan; 108(1):42-52. PubMed ID: 18173309
[TBL] [Abstract][Full Text] [Related]
18. Measurements of the pons as a biomarker of progression for pediatric DIPG.
Steffen-Smith EA; Baker EH; Venzon D; Shandilya S; Bent RS; Warren KE
J Neurooncol; 2014 Jan; 116(1):127-33. PubMed ID: 24113877
[TBL] [Abstract][Full Text] [Related]
19. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
20. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
